Magnus Höök, PhD, holds the position of Regents & Distinguished Professor and Neva & Wesley West Chair at Texas A&M University. His academic roles include: Adjunct Professor at Baylor College of Medicine Adjunct Professor at University of Texas M.D. Anderson Cancer Center Faculty member at University of Texas Health Science Center at Houston Graduate School of Biomedical Sciences Dr. Höök earned his B.S. in biochemistry and Ph.D. in medical chemistry from Uppsala University (Sweden). His research focuses on microbial adherence mechanisms and host defense evasion, with key areas including: Molecular pathogenesis of infections Extracellular matrix interactions Bacterial virulence factors (e.g., Staphylococcus aureus, Borrelia burgdorferi) Recent work highlights contributions to understanding: Decorin’s role in fibrin assembly Panton-Valentine leukocidin’s role in pneumonia Evolutionary dynamics of bacterial virulence No scientific awards are explicitly listed, though his academic chairs reflect recognition. Advising and grants are not detailed in the text. Dr. Höök leads the Höök Lab, focusing on translational research in infectious disease prevention and treatment.
Kristi L. Frank is an Associate Professor in the Department of Microbiology and Immunology at Uniformed Services University of the Health Sciences (USU) in Bethesda, MD. She holds a Ph.D. in Biomedical Sciences-Biochemistry and Molecular Biology from Mayo Clinic College of Medicine and completed postdoctoral research at the University of Minnesota. Education: 2002: B.S. in Microbiology and Medical Technology, The University of Montana 2007: Ph.D. in Biomedical Sciences-Biochemistry and Molecular Biology, Mayo Clinic College of Medicine Dr. Frank's research focuses on bacterial pathogenesis, particularly biofilm-associated infections. Her laboratory investigates Enterococcus faecalis biofilm formation, stress responses, and adaptation mechanisms, as well as developing novel methods to treat and prevent biofilm infections in multidrug-resistant bacteria including Enterococcus , Staphylococcus , Klebsiella , Acinetobacter , and Pseudomonas species. Her work combines animal models with genetic, molecular, and biochemical approaches to understand how bacterial pathogens interact with their hosts in biofilm environments. Analysis of her recent publications reveals a consistent focus on Enterococcus faecalis biofilm mechanisms, with particular attention to cell surface modifications, lysozyme resistance, and strain heterogeneity. Her research demonstrates how biofilms protect bacteria from host immune defenses and antimicrobial agents, contributing to persistent and difficult-to-treat infections. Dr. Frank has published extensively in high-impact microbiology journals including Journal of Bacteriology , Antimicrobial Agents and Chemotherapy , and PLoS Pathogens , with her work contributing significantly to understanding biofilm-mediated infections and potential therapeutic approaches. Her laboratory work has important implications for treating healthcare-associated infections, particularly those involving medical devices where biofilm formation is a major challenge.
Yucen Xie is a Researcher specializing in Food Science and Technology at the University of California, Davis. She is affiliated with Prof. Luxin Wang’s research group. Her work focuses on food safety mechanisms, particularly pathogen survival and thermal resistance in dry food systems, and cross-contamination risks during postharvest handling. She holds a Ph.D. in Food Engineering from Washington State University, an M.Eng. in Food Science and Engineering from China Agricultural University, and a B.S. in Food Quality and Safety from Shanghai Ocean University. Her research integrates microbiology and engineering principles to develop predictive models for foodborne pathogen control. Research interests include: Pathogen survival mechanisms in low-moisture foods Thermal inactivation kinetics of Salmonella and Enterococcus species Quantitative risk assessment for cross-contamination via food-contact surfaces Development of novel cooling media for food preservation Water activity and fat content effects on microbial thermal resistance Her recent work (2023-2025) emphasizes dry postharvest systems, particularly contamination dynamics in stone fruits, onions, and spices. Publications analyze bacterial transfer pathways and thermal treatment optimization strategies. No scientific awards were listed in the provided materials. Advising focuses on collaborative research within Prof. Wang’s lab group. Current research also explores biodegradable cooling solutions (Jelly IceCubes) and pulsed vacuum drying technologies. Ongoing projects aim to improve understanding of bacterial persistence in dry environments and develop practical food safety interventions.
Essam M. Abdelfattah serves as Assistant Professor in the Department of Animal & Veterinary Science at California State Polytechnic University, Pomona's Huntley College of Agriculture. His research integrates behavioral and physiological methodologies to enhance animal health and welfare through early disease detection technologies and stress mitigation strategies, with statewide extension leadership in dairy/beef cattle herd health and food safety. Education: PhD in Animal Behaviour and Welfare (2014), Purdue University & Benha University (Mutual supervision) MVetMed in Veterinary Medical Sciences (2008), Benha University BVetMed in Veterinary Medical Sciences (2004), Benha University (Class Rank: 1/250) Research Focus: Dr. Abdelfattah investigates environmental, nutritional, and management impacts on livestock welfare using advanced monitoring systems. His work spans poultry behavior, dairy/beef cattle health optimization, and antimicrobial resistance mitigation, emphasizing practical applications for California's agricultural industry through UC Davis collaborations. Publication Trends: Recent publications (2020-2024) demonstrate concentrated research on antimicrobial stewardship post-Senate Bill 27, dairy calf housing systems, and bovine disease management. His work consistently bridges veterinary science, behavioral analysis, and food safety through multi-institutional field studies across California dairies and international contexts. Scientific Recognition: 2023 CPP Professional Development Travel Award 2021 UC Davis Award for Excellence in Postdoctoral Research Multiple UC Davis Postdoctoral Travel Grants (2017-2019) Leaders for the Future Program Fellowship (UC Davis) Academic Engagement: Teaches core courses including Animal Behavior (AVS 3456) and Senior Seminar (AVS 4610), while directing extension programs that translate research into practical herd health protocols. His statewide outreach focuses on evidence-based management practices for dairy/beef producers, leveraging publications in Journal of Dairy Science and Antibiotics to inform industry standards. Professional Integration: Active in Veterinary Association for Farm Animal Welfare, American Veterinary Medical Association, and Dairy Calf and Heifer Association, with sustained membership in antimicrobial resistance research networks since 2017. His collaborative work with UC Davis and California dairies positions him at the forefront of sustainable livestock management innovation.
Susan L. Davis, Pharm.D., is Clinical Professor of Pharmacy Practice and Associate Dean for Pharmacy at Wayne State University’s Eugene Applebaum College of Pharmacy and Health Sciences, while simultaneously serving as Infectious Diseases Pharmacy Specialist at Henry Ford Hospital. Education & Training Doctor of Pharmacy, University of Michigan, 2002 Pharmacy Practice Residency, Detroit Receiving Hospital, 2003 Fellowship in Infectious Diseases Outcomes Research, Wayne State University, 2005 Research Interests Dr. Davis is internationally recognized for work in antimicrobial stewardship , epidemiology of resistant organisms , and economic outcomes of anti-infective therapy . Her investigations focus on optimizing antibiotic exposure, preventing resistance, and improving clinical outcomes in serious infections such as MRSA bacteremia, carbapenem-resistant Gram-negative pathogens, and Clostridioides difficile . Publication Themes Across more than 150 publications, her recent work (2019-2025) illustrates a clear trajectory toward pragmatic stewardship interventions—evaluating IV-to-PO switch strategies, real-world effectiveness of newer agents (ceftolozane-tazobactam, eravacycline, meropenem-vaborbactam), and pharmacist-led transitions-of-care models. Multiple multicenter cohort studies and randomized trials emphasize safety endpoints such as vancomycin nephrotoxicity and antifungal discontinuation guided by rapid diagnostics. Awards & Honors Wayne State University Board of Governors Faculty Recognition Award (2021) EACPHS Research Excellence Award (2015) Society of Infectious Diseases Pharmacists Outstanding Clinical Practice Award (2012) ASHP Foundation New Preceptor of the Year (2008) Roche & Henry Ford Preceptor of the Year distinctions (multiple years) Teaching & Mentorship Dr. Davis directs the infectious-disease pharmacotherapy sequence (PHA 5215) and precepts Pharm.D. candidates, residents, and fellows. She has built an extensive mentorship network, serving as primary research adviser for numerous Pharm.D. residents and graduate students whose projects feed into national MAD-ID research initiatives. Clinical & Administrative Roles At Henry Ford Hospital she leads antimicrobial stewardship rounds, while at Wayne State she oversees curriculum, accreditation, and strategic initiatives as Associate Dean. Her dual appointments integrate bench-to-bedside research with policy-level stewardship program development.
Prof. Dr. Rolf Daniel is Full Professor of Genomic and Applied Microbiology at the University of Göttingen, heading both the Department of Genomic and Applied Microbiology and the Göttingen Genomics Laboratory since 2012. He serves as Speaker of the North German Center of Microbial Genomics (NZMG) and previously directed the Institute of Microbiology and Genetics (2012-2016). His research pioneers cultivation-independent metagenomics and metatranscriptomics of environmental microbial communities from soil, sediments, ice, and biofilms. The lab employs dual function-based/sequence-based approaches to discover novel enzymes (proteases, cellulases, lipases) and genes, while conducting whole-genome sequencing of archaea/bacteria with industrial or pathogenic relevance. They also develop specialized bioinformatic tools for genomic data analysis and visualization. Recent publications reveal strong interdisciplinary trends: environmental microbiome responses to land-use changes (2018), viral genome evolution studies, and novel enzyme characterization from metagenomic libraries, spanning environmental science, medical microbiology, and industrial biotechnology. Scientific recognition includes: Norddeutscher Wissenschaftspreis (Northern German Science Award, 2013) No explicit details on student advising or grant funding were documented in source materials. Prof. Daniel directs the Göttingen Genomics Laboratory and the North German Center of Microbial Genomics (NZMG), driving collaborative research in microbial genomics across regional institutions through the GGNB graduate programs in Microbiology, Molecular Biology, and Genome Science.
Robert Britton is a Professor at the Baylor College of Medicine in the School of Medicine , affiliated with the Alkek Center for Metagenomics and Microbiome Research and the Department of Molecular Virology and Microbiology . His Therapeutic Microbiology Laboratory investigates how microbes impact human health through four pillars: Limosilactobacillus reuteri for therapeutics, intestinal hormone-microbiome interactions , synthetic biology for diagnostics , and microbial ecology in infectious disease . Research Themes : Microbiome-Host Physiology, Synthetic Biosensors, C. difficile Pathogenesis, Diet-Microbiome Co-evolution Grants : $12M NIH award (2018) for microbiome-based infection prevention The lab employs human organoid technology and microbioreactor arrays to model microbial interactions. Recent work explores probiotic-mediated oxytocin release and bioengineered Kv1.3 channel blockers for autoimmune diseases. A 2025 FASEB Journal study demonstrates L. reuteri 's role in gut hormone regulation, while synthetic biology projects target ulcerative colitis and radiation injury via engineered probiotics. Scientific Recognition : 2019 Michael E. DeBakey Excellence in Research Award Lab Members include MD/PhD candidates, postdoctoral fellows, and technicians working on microbiome-brain interactions, metabolic health interventions, and C. difficile epidemiology. Key collaborations span the National School of Tropical Medicine and Graduate School of Biomedical Sciences .
Caroline Charlier-Woerther is a distinguished Associate Professor of Medicine specializing in Infectious Diseases and Tropical Medicine at Paris Descartes University (Sorbonne Paris Cité) and a Senior Scientist at the French National Reference Center and WHO Collaborating Center on Listeria at the Institut Pasteur. She serves within the Biology of Infection Unit (Inserm U1117) and the Division of Infectious Diseases and Tropical Medicine at the Necker-Pasteur Center for Infectious Diseases, Assistance Publique–Hôpitaux de Paris. Her career bridges clinical practice, research, and academic teaching with a primary focus on listeriosis and other infectious diseases. Dr. Charlier-Woerther's research interests center on Listeria monocytogenes pathogenesis, particularly maternal-fetal transmission, neonatal listeriosis, and host genetic factors influencing susceptibility to infection. Her work examines how Listeria crosses critical biological barriers (intestinal, blood-brain, and placental) and the resulting clinical outcomes. She has made significant contributions to understanding neonatal listeriosis presentation and long-term neurological consequences, as well as antimicrobial resistance patterns in Listeria strains. Her extensive publication record in high-impact journals demonstrates her leadership in the field of listeriosis research. The recent publications reveal a consistent focus on clinical epidemiology of Listeria infections, neonatal outcomes, and antimicrobial resistance patterns. Her research combines clinical observation with molecular analysis to understand virulence heterogeneity and host adaptation of Listeria monocytogenes. Gold Medal of the Residency Program (Médaille d'Or du Concours de Médecine de l'Internat) 2005 Award CNRS/APHP for PhD program 2006 Young scientist award of the French Medical Mycology Society 2008 ASM ICAAC Infectious Diseases Fellows Grant at the 50th ICAAC in Boston 2010 Dr. Charlier-Woerther serves as Principal Investigator for two major research projects: LISTERIAGEN (ANR), which aims to identify host genetic factors associated with susceptibility to listeriosis, and MONALISA (Multicenter Observational National Analysis on Listeriosis and Listeria). She has received multiple research grants supporting her work on listeriosis and related infections. As an educator, she has taught infectious diseases since 2004 at Paris Descartes University Medical School and implemented an international infectious diseases course for students from multiple European institutions since 2014. She is actively involved in multiple professional organizations including the Faculty of 1000 Infectious Diseases, the Collège des Universitaires des Maladies Infectieuses et Tropicales, and the Editorial board of La Presse Médicale. Her work at the Necker-Pasteur Center for Infectious Diseases positions her at the forefront of clinical infectious disease management and research in France.
Laura Cook is an Assistant Professor in the Department of Biological Sciences at Binghamton University. Her research focuses on understanding how Gram-positive bacterial pathogens, particularly streptococci, colonize host mucosal surfaces like the vaginal tract and nasopharynx. She employs molecular, cell culture, and animal models to investigate bacterial genetic programs, interactions with host microbiota, and pathogenesis mechanisms. Education: Postdoctoral training at the University of Illinois at Chicago (UIC), followed by a PhD and a combined BS/BA from the University of Minnesota. Research Interests: Microbiology, microbial-host interactions, bacterial genetics, biofilm formation, heme utilization, and pathogen colonization dynamics. Her lab explores how bacterial species—both commensal and pathogenic—interact within host environments to influence disease outcomes, with applications to vaccine development and infection prevention. Publications highlight her work on streptococcal colonization mechanisms, heme transport proteins (e.g., HupZ), and the role of bacterial signaling systems (e.g., SaeRS) in pathogenesis. Recent studies emphasize vaginal and nasal tract colonization, biofilm formation, and the impact of host signals on bacterial behavior. Labs/Teams: The Cook Lab at Binghamton University investigates host-microbe interactions using interdisciplinary approaches, bridging molecular biology, microbiology, and infectious disease research.
Jessica Agius is a Postdoctoral Research Fellow at the Centre for Infectious Diseases and Microbiology - Public Health and the Sydney Infectious Diseases Institute , University of Sydney. Her work integrates molecular epidemiology and genomics surveillance to tackle infectious disease threats. Education : BAnVetBioSc (Hons I, 2016), PhD (2021) from University of Sydney Research Interests include: Molecular Microbiology Genomics Surveillance Antimicrobial Resistance One Health Publications highlight her focus on SARS-CoV-2 genomic variability, Enterococcus pathogenesis in reptiles, and adenovirus diversity in wildlife. Her work bridges in vitro and clinical cohort studies. Scientific Awards : Best Poster & Presentation (2018, Marie Bashir Institute) Academic Achievement Award (2016, Australian Society for Parasitology) Grants include Holsworth Wildlife Research Endowment and National Environmental Science Program funding. She supervises honours students on topics spanning reptile health and antimicrobial resistance.
Herb Schellhorn is a Professor in the Department of Biology within the Faculty of Science at McMaster University. His research spans fundamental bacterial genetics to applied environmental microbiology, with a particular focus on bacterial adaptation mechanisms and water quality monitoring. Dr. Schellhorn earned his B.Sc. and M.Sc. in Microbiology from the University of Guelph, followed by a Ph.D. in Microbiology from North Carolina State University. His academic background established the foundation for his expertise in bacterial stress response mechanisms and molecular microbiology. His laboratory primarily investigates bacterial genes that help cells adapt to sub-optimal growth conditions, with significant emphasis on the RpoS regulon. Early in his career, he focused on fundamental mechanisms of bacterial gene regulation, oxidative stress response, and DNA repair in Escherichia coli. More recently, his research has expanded to address critical environmental challenges, particularly in recreational water safety and pathogen detection in the Great Lakes region. His work combines DNA microarrays, real-time PCR, reporter fusions, and mass spectrometry with advanced genomic techniques to develop innovative solutions for water quality assessment. Analysis of his recent publications reveals a strategic evolution from pure bacterial physiology toward applied environmental microbiology. While maintaining his core interest in bacterial adaptation mechanisms, approximately 70% of his recent work (2023-2025) focuses on water quality monitoring, microbial source tracking, and recreational water safety. His research demonstrates exceptional methodological diversity, incorporating molecular diagnostics, metagenomics, and computational approaches to address public health challenges. Development of novel molecular methods for rapid water quality assessment Application of genomic technologies to environmental monitoring Investigation of bacterial adaptation in natural aquatic environments Creation of same-day testing protocols for recreational water safety Characterization of microbial communities in freshwater ecosystems Dr. Schellhorn actively contributes to teaching at McMaster University, instructing courses including Medical Microbiology (MOLBIOL 6P03 and 4P03), Introductory Biology (BIOLOGY 1P03), and Techniques in Molecular Genetics (MOLBIOL 3V03). His teaching reflects his research expertise, bridging theoretical knowledge with practical laboratory skills in molecular biology and microbiology. His laboratory serves as a training ground for students interested in both fundamental bacterial physiology and applied environmental microbiology.
Ashlan J. Kunz Coyne, PharmD, MPH is an Assistant Professor in the Department of Pharmacy Practice & Science at the University of Kentucky, specializing in infectious diseases pharmacy with a focus on antimicrobial pharmacokinetics/pharmacodynamics (PK/PD) and multidrug-resistant bacteria. Education & Training Doctor of Pharmacy (PharmD), University of Florida PGY1 Pharmacy Practice Residency, UF Health Jacksonville PGY2 Infectious Disease Pharmacy Practice Residency, UF Health Jacksonville Master of Public Health (MPH), Wayne State University ACCP peer-reviewed PK/PD & Health Outcomes Pharmacotherapy Fellowship, Wayne State University Research Focus Dr. Kunz Coyne’s research leverages precision PK/PD modeling and multi-omics approaches to optimize antimicrobial regimens against resistant pathogens. Her work spans: Phage–antibiotic synergy against MRSA, Pseudomonas aeruginosa , and Enterococcus spp. Clinical outcomes of novel β-lactam/β-lactamase inhibitors (ceftazidime-avibactam, cefiderocol, eravacycline) Obesity-related PK alterations and their impact on antimicrobial efficacy Penicillin allergy de-labeling strategies in outpatient settings Antimicrobial stewardship aided by rapid molecular diagnostics Scientific Recognition National Institutes of Health Loan Repayment Program (NIH LRP) Award Grants & Future Directions Supported by the NIH LRP, Dr. Kunz Coyne aims to expand translational PK/PD studies that integrate clinical data with in-vitro and ex-vivo models to inform evidence-based dosing for high-risk populations, including immunocompromised and critically ill patients. Laboratory & Teams She collaborates closely with interdisciplinary teams across the University of Kentucky College of Pharmacy, infectious diseases divisions, and external multicenter networks to conduct prospective cohort studies and real-world evidence analyses.
Dr. Charles Knapp is a Reader in the Department of Civil and Environmental Engineering at the University of Strathclyde. He serves as Director of Postgraduate Studies and actively contributes to the Water, Environment, Sustainability and Public Health (WESP) research center. His work integrates advanced molecular microbiology techniques with ecological principles to address environmental sustainability challenges. Doctor of Philosophy (2002) - University of Kansas Master of Science (1999) - University of Kansas Bachelor of Science (1994) - University of Kansas His research focuses on: Antimicrobial resistance in aquatic and terrestrial ecosystems Microbial community stability under pollution stress Bioremediation of emerging contaminants Eco-toxicology and pollutant impact assessment Culture-independent molecular microbial analysis Historical antimicrobial mineral studies Recent publications examine antibiotic resistance patterns in Arctic and Scottish environments, historical microbial remedies, and fisheries governance. His work aligns with UN Sustainable Development Goals for clean water, health, and sustainability. Scientific recognition includes: Fellow of the Higher Education Academy (2015) Multiple Teaching Excellence Awards nominations (2014-2018) Researcher Development Programme Supervisor nomination He supervises PhD projects in antimicrobial resistance and microbial ecology, and leads international collaborations across six continents. Key projects include: AWARE (Amoebae With Antimicrobial Resistant Endosymbionts) DAGGAR (Dangerous and Growing Globally, Antimicrobial Resistance) ARMOR (Antimicrobial Resistance May Offer Resilience) GR-AMS (Greco-Roman Antimicrobial Minerals)
Colonel David R. Stagliano, MD, is a faculty member at the Uniformed Services University of the Health Sciences (USUHS) School of Medicine, Department of Pediatrics. He currently serves as the Pediatric Infectious Diseases Fellowship Program Director at Walter Reed National Military Medical Center (WRNMMC) in Bethesda, MD. Education : Doctor of Medicine (Virginia Commonwealth University, 2003); Fellowship in Pediatric Infectious Diseases (National Capital Consortium, 2008–2011); Residency and Internship in Pediatrics (NCC, 2003–2006); Bachelor of Science in Biochemistry-Philosophy (University of Scranton, 1999, Summa Cum Laude). Dr. Stagliano’s research focuses on childhood respiratory infections , especially Respiratory Syncytial Virus (RSV) in vulnerable populations like Down syndrome patients and late-preterm infants. He also investigates tropical medicine , antimicrobial resistance (e.g., Vancomycin-Resistant Enterococcus), and clinical applications of immune plasma therapy for viral infections. His work bridges clinical practice, military deployments, and public health strategies. Selected publications highlight his contributions to travelers’ diarrhea treatment guidelines, simulation training for combat medicine, and infectious disease epidemiology in military health systems. He has deployed multiple times in support of operations in Iraq, Afghanistan, and Africa, integrating clinical expertise with operational readiness. Scientific Awards : Bronze Star Medal (OEF deployment), Defense Meritorious Service Medal, Flight Surgeon Badge, Walter Reed Master Clinician designation. As an educator, he has led the NCC Transitional Internship Program (2014–2018) and Pediatric Residency Program (2018–2021), emphasizing clinical training and infectious disease management. His military education includes advanced courses in chemical defense and tactical combat medicine.
Oscar Kuipers is Professor of Molecular Genetics of Prokaryotes at the University of Groningen, affiliated with the Department of Molecular Genetics within the Groningen Biomolecular Sciences and Biotechnology Institute. His research focuses on prokaryotes—microorganisms without nuclei such as bacteria and cyanobacteria—and the molecular genetic mechanisms governing their functions and interactions. Kuipers studied Biology at Utrecht University, where he also earned his PhD in Biochemistry in 1990. Following his doctoral studies, he worked at NIZO Food Research in Ede and the Wageningen Centre for Food Sciences before joining the University of Groningen. His research interests center on antimicrobial peptides, particularly lanthipeptides like nisin, and their applications in combating antibiotic-resistant bacteria. Kuipers investigates gene regulation, peptide engineering, and the biosynthesis of ribosomally synthesized and post-translationally modified peptides (RiPPs). His work bridges fundamental molecular genetics with practical applications in biotechnology and medicine, with a strong emphasis on developing novel antimicrobial strategies against drug-resistant pathogens. Analysis of Kuipers' recent publications reveals a consistent focus on peptide engineering, particularly modifications to nisin and related antimicrobial compounds. His research spans structural modifications to enhance stability and specificity, exploration of novel lanthipeptides from diverse bacterial sources, and investigation of mechanisms by which these compounds interact with bacterial pathogens. A significant portion of his recent work addresses the growing crisis of antibiotic resistance through innovative approaches to peptide-based antimicrobials. Simon Stevin Master Award (2011) with €500,000 research grant Elected member of the Royal Netherlands Academy of Arts and Sciences (KNAW) (2011) €1 million EU grant for synthetic peptides development, particularly for new antibiotics (2013) NWO subsidy for developing microscopic techniques to study intracellular processes (2012) Kuipers actively supervises the University of Groningen student team in the international iGEM competition, which achieved world champion status in 2012 with a biological detection system for meat freshness. He is also co-founder and director of the Centre for Sustainable Antimicrobials (CeSAM), a collaborative initiative between the University of Groningen and University Medical Center Groningen focused on breaking down disciplinary boundaries to accelerate the development of new antibiotics. His laboratory work centers on the Groningen Biomolecular Sciences and Biotechnology Institute, where his team employs advanced techniques in genetic engineering, peptide synthesis, and microbiological analysis to develop and characterize novel antimicrobial compounds. The research environment fosters interdisciplinary collaboration between microbiologists, biochemists, and biotechnologists working toward the common goal of addressing antimicrobial resistance.
